Website profile

@Kslcom

Utah's #1 source for News, Sports, Weather, Cars, Classifieds and more

  • 1,019articles · 30d
  • 2+ hour agolatest article
  • Aug 15, 2026earliest in window
  • 73%with images · 9 videos
  • 320avg words
articles per day
Categories
  • Sensitive Subjects 244
  • Sports & Fitness 192
  • Sports 179
  • Crime & Law 164
  • News 157
  • Sport 154
  • Crime, Law & Justice 147
  • Disaster, Accident & Emergency Incident 137

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

@kslcom
ksl.com > article > 51/62/1637 > why-your-insurance-company-doesnt-want-you-to-get-an-mri

Why your insurance company doesn't want you to get an MRI

4+ day, 13+ hour ago   (832+ words) Paying for health insurance does not guarantee affordable access to medical imaging. In fact, for patients with high-deductible plans, getting an MRI can mean navigating extra fees, authorization requirements, and delays before they ever get an answer. You first have…...

@kslcom
ksl.com > article > 51/62/1605 > blackstone-explores-sale-of-zo-skin-health-sources-say

Blackstone explores sale of ZO Skin Health, sources say

4+ day, 21+ hour ago   (154+ words) NEW YORK, Sept 8 — Investment ​firm Blackstone is looking to sell medical-grade skincare company ZO Skin ‌Health, which could be valued at around $2 billion ⁠in any deal, ​according to people ⁠familiar with the matter. The firm ‌is working with ‌investment bankers…...

@kslcom
ksl.com > article > 51/62/1365 > ai-healthcare-platform-forus-valued-at-3-billion-in-latest-funding-round

AI healthcare platform Forus valued at $3 billion in latest funding round

5+ day, 15+ hour ago   (191+ words) Sept 8 — AI healthcare platform Forus said on Tuesday it ​has raised $150 million in a funding round that valued the company at $3 billion, ‌tripling its valuation in about four months. • ⁠The Series C round ​was led by Bain ⁠Capital Ventures, which…...

@kslcom
ksl.com > article > 51/62/0905 > novartis-shares-down-as-failed-cholesterol-drug-study-increases-pipeline-pressure

Novartis shares down as failed cholesterol drug study increases pipeline pressure

6+ day, 23+ hour ago   (144+ words) LONDON, Sept 7 — Shares of Novartis fell ​3.3% on Monday morning after its cholesterol drug failed in ‌a closely watched study, casting fresh doubt ⁠on the ​therapeutic approach and ⁠raising the stakes for the ‌Swiss drugmaker's ‌upcoming data for a gene therapy....

@kslcom
ksl.com > article > 51/62/0375 > ionis-novartis-key-experimental-heart-drug-fails-in-late-stage-trial

Novartis, Ionis' experimental heart drug misses key goal in closely watched trial

1+ week, 2+ day ago   (457+ words) Sept 4 — Novartis said on Friday its experimental drug pelacarsen did not cut the risk of major heart attacks and ​strokes in patients with a genetic risk factor in a late-stage trial, marking a setback to the Swiss drugmaker's efforts to…...

@kslcom
ksl.com > article > 51/61/1612 > moderna-merck-vaccine-cuts-recurrence-and-spread-of-melanoma-raising-new-treatment-hope

Moderna, Merck vaccine cuts recurrence and spread of melanoma, raising new treatment hope

3+ week, 4+ day ago   (726+ words) BOSTON — Moderna and Merck said on Wednesday that a personalized mRNA cancer vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a new field ​of cancer treatment that sent Moderna's shares…...